In order to examine the extent of xenograft vascularization and proliferation, tumor sections from each treatment group were subjected to H&E staining (in order to confirm malignancy; Figure 4C) and then to IHC staining using markers of microvessel density (CD31) and tumor cell proliferation (Ki-67). Here, MKI67 is linked to neoplasm.